Laser Focus World magazine recognizes the ESI CapStone system with its Innovators Award. PORTLAND, Ore., Sept. 27, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its ESI Read more
MENLO PARK, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of Pacific Biosciences common stock,... Read more
Pfizer executive brings strong scientific and medical expertise to Agilent board SANTA CLARA, Calif., September 23, 2021 Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to Agilent’s board of directors, effective Sept. 21, 2021. Dr. Dolsten brings... Read more
WASHINGTON, Sept. 21, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2021 on Thursday, October 21, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more
HAMBURG, Germany, September 20, 2021 / B3C newswire / — Cellbox Solutions GmbH, developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market. Following the successful development and production of the Cellbox transportable CO2 incubator in 2019, as well as suitable UN3373 packaging materials for cell transport, the young... Read more
Gavreto showed robust and durable clinical responses in people with NSCLC with RET fusions If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC Basel, 17 September 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the... Read more
Roderick de Greef Concludes 20 Year Association with BioLife BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ — BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Roderick de Greef, Chief Financial Officer, plans to retire on December 31,... Read more
Sep 15, 2021 Diverse investments from Israel, Mexico, Poland, South Africa, United Kingdom and United States SAN DIEGO, Sept. 15, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups,... Read more
Oncomine Dx Target Test Receives MHLW Approval as a Companion Diagnostic for Eli Lilly’s RET-Inhibitor in Non-Small Cell Lung Cancer in Japan CARLSBAD, Calif., Sept. 10, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the Japan Ministry of Health, Labour and Welfare (MHLW), Japan’s regulatory agency, has granted approval for the Oncomine Dx Target Test as... Read more
Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. Sustain and secure the supply chain for customers in China and the broader region. With the use of Fortem™ film, Cytiva helps customers speed up their clinical manufacturing and product launches; improve... Read more